▶ 調査レポート

いびき治療の世界市場:技術別、地域別分析

• 英文タイトル:Global Anti-snoring Treatment Market - Segmented by Treatment Technique and Geography - Growth, Trends, and Forecast (2018 - 2023)

が調査・発行した産業分析レポートです。いびき治療の世界市場:技術別、地域別分析 / Global Anti-snoring Treatment Market - Segmented by Treatment Technique and Geography - Growth, Trends, and Forecast (2018 - 2023) / B-MOR-06001資料のイメージです。• レポートコード:B-MOR-06001
• 出版社/出版日: / 2018年6月20日
• レポート形態:英文、PDF、105ページ
• 納品方法:Eメール(受注後2営業日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User(1名様用)¥629,000 (USD4,250)▷ お問い合わせ
  Team User(7名様用)¥666,000 (USD4,500)▷ お問い合わせ
  Corporate User¥1,295,000 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、いびき治療の世界市場について調べ、いびき治療の世界規模、市場動向、市場環境、技術別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、関連企業情報などをまとめた調査レポートです。
・イントロダクション
・エグゼクティブサマリー
・いびき治療の世界市場インサイト
・いびき治療の世界市場環境
・いびき治療の世界市場動向
・いびき治療の世界市場規模
・いびき治療の世界市場規模:技術別
・いびき治療の世界市場:地域別市場規模・分析
・いびき治療の北米市場規模・予測
・いびき治療のアメリカ市場規模・予測
・いびき治療のヨーロッパ市場規模・予測
・いびき治療のアジア市場規模・予測
・関連企業情報・競争状況

The global anti-snoring treatment market is expected to register a CAGR of about 7.5% during the forecast period, 2018-2023. An increase in the number of people suffering from snoring is one of the major factors creating the demand for user-friendly, efficacious, and economical anti-snoring devices, thus, driving the anti-snoring treatment market. The Asia-Pacific region is expected to provide high growth opportunities for the anti-snoring treatment market. Due to factors, such as the diversified patient pool, improving healthcare, and developing economies in the emerging markets, the anti-snoring treatment market is expected is expand quickly over the forecast period.

Increase in Obesity and Geriatric Population
Increasing obesity and a rise in geriatric population are some of the primary factors driving the demand for the anti-snoring treatment market. According to the World Health Organization (WHO), the obese population tripled between 1975 and 2016. WHO also states that, in 2016, more than 1.9 billion adults were overweight and over 650 million were in the obese category. Among children, more than 40 million below the age of five were overweight or obese. Snoring is highest among the population aging between 40 to 60 years old.
Other factors driving this market are increasing smoking and alcohol consumption, technological advancements in anti-snoring devices, and increased awareness among the population in the developed markets.

Social Stigma Associated with Snoring
The social stigma associated with snoring is among the major factors hindering the usage of these of devices and surgical equipment in certain regions. Both, male and female population are affected by traditional prejudices and it often leads to sleep apnea remaining undiagnosed for years. In many cases, patients are incorrectly diagnosed with other indications, such as menopausal changes, anemia, diabetes, hypertension, and depression among others. Many patients relate snoring to laziness and lack of ambition, which restricts them from approaching physicians and doctors for using devices or opting for surgical procedures.
Other factors affecting this market are the high cost of custom-made oral devices, poor efficacy, and lack of scientific validation of the anti-snoring devices.

Asia-Pacific is Expected to have High Growth Opportunites
The Asia-Pacific region has a large diversified patient population, improving healthcare infrastructure, and countries with high economic growth in past few years, such as India and China. The Asia-Pacific region is dominated by private hospitals, community healthcare, home healthcare, and sleep clinics. As per the WHO, Australia, Thailand, Malaysia, and South Korea are the countries with high obese and overweight population, and India and Vietnam are among the least. The countries in the Asia-Pacific region have a range of life sciences companies with innovative medical research facilities that attract major multinational players, thus, increasing the growth opportunities over the forecast period.

Key Developments in the Market
• Feb 2018 – The Center for Craniofacial & Dental Sleep Medicine (CFDSM) received FDA clearance for obstructive sleep apnea (OSA) and snoring appliance: The Meridian PM oral appliance.

Major Players: ACCUMED CORP, APNEA SCIENCES, FISHER & PAYKEL HEALTHCARE LIMITED, KONINKLIJKE PHILIPS NV, MEDITAS, RESMED, SOMNOMED, THE PURE SLEEP COMPANY, TOMED GMBH, AND WHOLE YOU INC., amongst others.

Reasons to Purchase this Report
• Current and future anti-snoring treatment market outlook in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in excel)

Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs

レポート目次

1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry
5.3 Regulatory Scenario
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increase in Obesity and Geriatric Population
6.1.2 Increasing Smoking and Alcohol Consumption
6.1.3 Technological Advancements in Anti-snoring Devices
6.1.4 Increased Awareness in the Developed Markets
6.2 Market Restraints
6.2.1 High Costs of Custom-Made Oral Devices
6.2.2 Poor Efficacy and Lack of Scientific Validation of the Anti-snoring Devices
6.2.3 Social Stigma Associated with Snoring
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Treatment Technique
7.1.1 By Device
7.1.1.1 Mandibular Advancement Devices (MAD)
7.1.1.2 Tongue Stabilizing Devices (TSD)
7.1.1.3 Continuous Positive Airway Pressure (CPAP) Devices
7.1.1.4 Nasal Devices
7.1.1.5 Others
7.1.2 By Surgical Procedure
7.1.2.1 Uvulopalatopharyngoplasty (UPPP)
7.1.2.2 Somnoplasty
7.1.2.3 Pillar Procedure
7.1.2.4 Tonsillectomy
7.1.2.5 Radiofrequency Palatoplasty
7.1.2.6 Others
7.2 By Geography
7.2.1 North America
7.2.1.1 United States
7.2.1.2 Canada
7.2.1.3 Mexico
7.2.2 Europe
7.2.2.1 France
7.2.2.2 Germany
7.2.2.3 United Kingdom
7.2.2.4 Italy
7.2.2.5 Spain
7.2.2.6 Rest of Europe
7.2.3 Asia-Pacific
7.2.3.1 China
7.2.3.2 Japan
7.2.3.3 India
7.2.3.4 Australia
7.2.3.5 South Korea
7.2.3.6 Rest of Asia-Pacific
7.2.4 Middle East & Africa (MEA)
7.2.4.1 GCC
7.2.4.2 South Africa
7.2.4.3 Rest of MEA
7.2.5 South America
7.2.5.1 Brazil
7.2.5.2 Argentina
7.2.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers and Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 AccuMED Corp
9.2 Apnea Sciences
9.3 Fisher & Paykel Healthcare Limited
9.4 Koninklijke Philips NV
9.5 Meditas
9.6 ResMed
9.7 SomnoMed
9.8 The Pure Sleep Company
9.9 Tomed GmbH
9.10 Whole You Inc.
*List Not Exhaustive
10. Future of the Market